- IBD
-
Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
-
Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja
-
Intest Res 2022;20(2):269-273. Published online February 8, 2022
-
DOI: https://doi.org/10.5217/ir.2021.00064
-
-
PDFSupplementary MaterialPubReaderePub
-
Citations
Citations to this article as recorded by
- Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world
Partha Pal, Rupa Banerjee, Polina Vijayalaxmi, D. Nageshwar Reddy, Manu Tandan Indian Journal of Gastroenterology.2024; 43(1): 226. CrossRef - Research Progress in the Study of Biomarkers for Diagnosing Ulcerative Colitis or Assessing Its Activity
琳 杨 Advances in Clinical Medicine.2024; 14(01): 1167. CrossRef - A novel serum biomarker of endoscopic mucosal healing in inflammatory bowel disease
Hyoun Woo Kang Intestinal Research.2024; 22(1): 3. CrossRef - The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross‐sectional study
Dipesh H. Vasant, Gaurav B. Nigam, Sebastian Bate, Shaheen Hamdy, Jimmy K. Limdi Alimentary Pharmacology & Therapeutics.2023; 58(1): 26. CrossRef - Current and emerging biomarkers for ulcerative colitis
Jan K. Nowak, Rahul Kalla, Jack Satsangi Expert Review of Molecular Diagnostics.2023; 23(12): 1107. CrossRef
-
4,027
View
-
278
Download
-
4
Web of Science
-
5
Crossref
|